INTRODUCTION
Parry-Romberg Syndrome (PRS) was first described by Parry in 1825 and by Romberg in 1946 1 . It is a rare neurocutaneous disorder that is characterized by loss of skin, subcutaneous fat, and muscles of the face resulting in unilateral atrophy. It can even involve bone, teeth, hair and eyes 2 . Usually it starts in the second division of the trigeminal nerve, followed by the first and third division 3 . Until now, the two prominent treatments for PRS were autologous fat graft and surgical flap [4] [5] [6] . However, these treatments need complicated surgical skills which take a lot of time and cost. The objective of this study is to report that hyaluronic acid (HA) filler can be used as a safe, simple, and even rational economic alternative for the treatment of PRS. We received the patient's consent form about publishing all photographic materials.
CASE REPORT
A 42-year-old female patient came to dermatology clinic for the correction of facial hemiatrophy and hyperpigmentation on the right side of the face (Fig. 1A, 2A . One month after the first filler injection, additional 1.5 ml hyaluronic acid (HA) filler was injected on the chin (C). One year after first injection, additional 3 ml HA filler was injected on the chin (D).
Fig. 2.
Lateral views of the patient. At first visit, we planned to inject fillers in the direction of the arrows with fanning technique (A). After subcision with the cannula, total 7 ml of filler was injected via two holes on the cheek and chin (B). One month after the first filler injection (C). One year after first injection (D).
HA Filler was injected via 23 gauge cannula pulling the needle back. A total of 7 ml of filler was used: 4 ml of HA filler was injected into the cheek, and the remaining 3 ml was injected into the mandibular area (Fig. 1B, 2B ). Because the adhesion between facial skin and subcutaneous fat was too tight to inject HA filler, we made a split space by subcision with a cannula before HA filler injection. A part of depressed area would need to be recontoured by second filler injection, however the patient was satisfied with cosmetic result and did not want to undergo another painful subcision. So we finished injecting further HA filler. It only took about 30 minutes for the procedure overall. One month after the first injection, additional 1.5 ml of HA filler was injected using fanning technique on the chin (Fig. 1C, 2C ). After 1 year later, additional therapy was done with 3 ml of HA filler, significant improvement of contour of left chin was seen (Fig. 1D, 2D) . Two months later, she did not show any signs of atrophy, and she was satisfied with the procedure. Also, there were no adverse events such as bruising, tenderness, overcorrection, chewing discomfort, Tyndall effect, the occlusion of the vessel or foreign body reaction. The physician should also consider the possibility of surgical complications such as graft failure, hematoma, infection, scar and the quality of life after flap or graft. Moreover, our patient was too thin (body weight, 45 kg) to obtain autologous donor fat. If the patient also had severe bony abnormality, we would definitely have considered surgical flap including bone augmentation and multiple stage treatment 10 . But the patient has no bony abnormality, thus finding the simplest and safest method is best for her. These days, numerous fillers are widely used in cosmetic fields such as the correction of nasolabial fold or tear trough, rhinoplasty, forehead augmentation and other depressed scar. These fillers can also be applied for depression of PRS. Until now, two PRS cases treated by fillers have been reported and one was with calcium hydroxylapatite (CaHA) and the other was with permanent polyacrylamide hydrogel (PAAG) filler 7, 11 . CaHA has a dramatic volumizing effect. After injection, the gel carrier is promptly spread out into adjacent tissue, and the remaining CaHA stimulates secondary collagen generation 7 12 . Because it shows a good safety profile and can be hydrolyzed by hyaluronidase, it had been used for facial fat atrophy in HIV-positive patients 13, 14 . HA has identical chemical composition in all species and tissues 15 . Furthermore
DISCUSSION
Restylane® (Q-Med) is an non-animal stabilized hyaluronic acid produced by fermentation of streptococcal bacteria 15 .
Thus it has less antigenic effect and is thought to induce less hypersensitivity reaction than animal source products 13 . Because Restylane SubQ® (Q-Med) has larger gel particle size (approximately 1,000 particles/ml) than Restylane® (Q-Med), it is more suitable for contouring the cheeks and the chin 15 . Also for the fine volumizing effect in upper dermal layer, we mixed Restylane SubQ® (QMed) with Restylane Vital® (Q-Med). Generally, Restylane Vital® (Q-Med), which has the smallest particle size among all of the Restylane® (Q-Med) fillers, has been used for facial hydrofilling or hydrolifting in Korea 16 .
In conclusion, HA filler has been widely used by dermatologists, which means that many dermatologists would prefer HA filler rather than flap, graft or other filler material. So, we suggest that HA filler will be the simplest and safest way for the correction of atrophy in PRS patient.
